ENZ enzo.com Full Business Value

Enzo Biochem, Inc. (ENZ) specializes in developing molecular biology tests for the pharmaceutical sector and clinics. The asset's market valuation trend is , which correlates with high liquidity following the divestiture of its laboratory business and a strategic focus on patents. The firm's success relies on the expertise of biochemists, who are attracted by the organization's scientific standing and opportunities for professional growth in medicine.

ENZ Enzo Biochem: Enterprise Value in the range 07/04/2022 - 10/27/2026

Enzo Biochem (ENZ) - metric breakdowns and financial figures

- price and consensus price forecast:

Share Price Enzo Biochem Inc.|ENZ - Consensus Target

- market capitalization data:

Market Valuation Enzo Biochem|ENZ - Total Company Value

- book capitalization data:

Accounting Value per Share Enzo Biochem|ENZ - Book Capitalization|Market-to-Book Ratio enzo.com|ENZ - Company Total Assets

- debt and liquidity data:

Debt to Equity Ratio Enzo Biochem, Inc.|ENZ - Long-Term Debt to Capital|Short-Term Debt to Capital Enzo Biochem Inc.|ENZ - Company Debts|Debt to Book Value Ratio Enzo Biochem

Initial company analysis:ENZ (Enzo Biochem, Inc.)

An investor determines an asset's margin of safety through the sum of market capitalization and net debt, which allows for the identification of the real buyout cost of a business without illusions. For Enzo Biochem, Inc. (ENZ), which holds a valuable portfolio of diagnostic patents, the company's aggregate valuation level reflects the balance between the value of its intellectual property and its debt load, characterizing the asset as a speculative biotech instrument.

Who Enzo Biochem, Inc. competes with

A - Business Value|Real Price to Acquire Entire Company Quest|ILMN: Full Business Value|EXAS (Exact Sciences) - Total Company Value|revvity.com (RVTY) - Real Price to Acquire Entire Company|Enterprise Value BIO (Bio-Rad)|Total Enterprise Value Anbio Biotechnology Ltd|Enterprise Value Sterigenics SHC|Business Value QuidelOrtho Inc. (QDEL)|Enterprise Value OPK (OPKO Health, Inc.)|CareDx Health - Enterprise Value|Maravai LifeSciences Holdings, Inc. (MRVI) - Total Company Value|FLGT - Business Value|LAB: Enterprise Value|CTKB (Cytek Corp) - Enterprise Value|Total Company Value OraSure Technologies|Total Company Value Exagen Diagnostics (XGN)|MDxHealth - Real Price to Acquire Entire Company|Total Enterprise Value LUCD (Lucid Diagnostics, Inc.)|Total Company Value PRE|Company Buyout Price Insight Molecular Diagnostics, Inc. IMDX|Enterprise Value TRIB (Trinity Biotech Corp)|PRPH: Company Buyout Price|Ainos - Total Company Value|Co-Diagnostics Inc (CODX) - Company Buyout Price|Enterprise Value HSCS (Heart Test Laboratories Inc.)|Total Enterprise Value BMRA|Total Company Value Cardio Diagnostics CDIO|Business Value viraxbiolabs.com VRAX|Bluejay Diagnostics, Inc. (BJDX) - Real Price to Acquire Entire Company|Aspira Women's Health, Inc. - Full Business Value|AXDX (Accelerate Diagnostics, Inc) - Total Company Value|Centogene N.V. (CNTG) - Total Enterprise Value|Real Price to Acquire Entire Company fresh2.co FRES|Genetic Technologies Limited (GENE) - Value Adjusted for Debt and Cash|Enterprise Value 23andMe|Total Company Value Psychemedics Corp.